Lifetime cost-utility analysis of patients with refractory epilepsy treated with adjunctive topiramate therapy : cost-effectiveness in refractory epilepsy.

2003

Objective To evaluate the cost-effectiveness profile of topiramate as adjunctive treatment in patients with refractory epilepsy.

Keywords:

References

Citations